ClinConnect ClinConnect Logo
Search / Trial NCT03600857

Medical Termination of II Trimester Pregnancy

Launched by KAROLINSKA INSTITUTET · Jul 16, 2018

Trial Information

Current as of June 05, 2025

Completed

Keywords

Medical Abortion Mifepristone Misoprostol Home Use

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women aged \>/= 18 years requesting a termination of pregnancy, for social, medical or foetal indications
  • gestational age 85 - 153 days (with ultrasonography),
  • willing and able to understand and participate after the study has been explained, with good understanding of Swedish or English language,
  • general good health,
  • single intra-uterine pregnancy,
  • Exclusion Criteria:
  • do not wish to participate or unable to communicate in Swedish or English.
  • non-viable pregnancy (confirmed by ultrasonography).
  • a history or evidence of disorders that represent a contraindication to the use of Mifepristone or Misoprostol (adrenal pathology, steroid dependent cancer, porphyria, known allergy to the medication).
  • any pre-existing health conditions for whom the execution of a medical abortion as judged by the investigator could compromise their condition (Examples of health conditions of concern are: severe anaemia, severe asthma, haemorrhagic disorders, treatment with anticoagulants or corticoids, severe cardiac disease or hypertension, severe liver disease, severe kidney disease or severe psychiatric disorders).
  • Fetal malformation that may impact time-to-expulsion (such as hydrocephalus, hydrops/edema) or a duplex pregnancy.

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Stockholm, Danderyd, Sweden

Stockholm, Solna, Sweden

Gothenburg, , Sweden

Stockholm, , Sweden

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials